The mammalian AP-endonuclease (APE1/Ref-1) plays a central role in the repair of oxidized and alkylated bases in mammalian genomes via the base excision repair (BER) pathway. However, APE1, unlike its E. coli prototype Xth, has two unique and apparently distinct transcriptional regulatory activities. APE1 functions as a redox effector factor (Ref-1) for several transcription factors including AP-1, HIF1-␣, and p53. APE1 was also identified as a direct trans-acting factor for repressing human parathyroid hormone (PTH) and renin genes by binding to the negative calcium-response element (nCaRE) in their promoters. We have characterized APE1's post-translational modification, namely, acetylation which modulates its transcriptional regulatory function. Furthermore, stable interaction of APE1 with several other trans-acting factors including HIF-1␣, STAT3, YB-1, HDAC1, and CBP/p300 and formation of distinct trans-acting complexes support APE1's direct regulatory function for diverse genes. Multiple functions of mammalian APE1, both in DNA repair and gene regulation, warrant extensive analysis of its own regulation and dissection of the mechanisms. In this review, we have discussed APE1's own regulation and its role as a transcriptional coactivator or corepressor by both redox-dependent and redox-independent (acetylation-mediated) mechanisms, and explore the potential utility of targeting these functions for enhancing drug sensitivity of cancer cells. Antioxid. Redox Signal. 11,[621][622][623][624][625][626][627][628][629][630][631][632][633][634][635][636][637]

The mammalian abasic endonuclease, APE1, has two distinct roles in the repair of oxidative DNA damage and in gene regulation. Here we show that both functions are essential for cell survival. Deletion of the APE1 gene causes embryonic lethality in mice, and no nullizygous embryo fibroblasts have been isolated. We have now established nullizygous embryo fibroblast lines from APE1 ؊/؊ mouse embryos that are transgenic with the ''floxed'' human APE1 (hAPE1) gene. Removal of hAPE1 by Cre expression through nuclear microinjection elicited apoptosis in these cells within 24 h, which was blocked by coinjection of the wild-type hAPE1 gene. In contrast, mutant hAPE1 alleles, lacking either the DNA repair or acetylation-mediated gene regulatory function, could not prevent apoptosis, although the combination of these two mutants complemented APE deficiency induced by Cre. These results indicate that distinct and separable functions of APE1 are both essential for mammalian cells even in vitro and provide the evidence that mammalian cells, unlike yeast or Escherichia coli, absolutely require APE for survival, presumably to protect against spontaneous oxidative DNA damage.conditional gene inactivation ͉ DNA repair ͉ endogenous DNA damage ͉ base excision repair A basic endonuclease (APE), a ubiquitous enzyme, plays a central role in repairing toxic and mutagenic abasic (AP) sites generated in genomes during the repair of oxidation and alkylation damage through the base excision repair (BER) pathway (1). Oxidative DNA lesions, including AP sites, are also spontaneously generated at an estimated rate of 1.5 ϫ 10 5 residues⅐cell Ϫ1 ⅐day Ϫ1 (2). Unlike two distinct APEs present in Escherichia coli and Saccharomyces cerevisiae, only one active APE, APE1, an ortholog of E. coli xth and yeast APN2, has been identified in mammalian cells (3). Based on sequence homology, a second APE-like gene, APE2, was cloned from mammalian cells. However, we could not detect APE activity in the recombinant human APE2 (4), and hAPE2, unlike hAPE1, could not complement yeast APE mutants (5). Although APE-negative bacteria and yeast are viable, very early death (3.5-7.5 days after fertilization) was observed in APE1 nullizygous mouse embryos (6-8). Unlike other BER proteins, e.g., DNA polymerase ␤ and X-ray cross complementation group 1, which are essential for embryonic survival but not for mouse embryonic fibroblasts (MEFs) cultured in vitro (9, 10), APE1-null MEF mutant lines have not been established. The mammalian APE1, independently identified as redox-enhancing factor 1 (Ref1), has a distinct regulatory function in reductively activating C-Jun, p53, and other transcription factors (3, 11) for which Cys-65 (Cys-64 in mouse APE1) was identified as the active site (12). The N-terminal region of the 36-kDa polypeptide, including Cys-65, is not conserved in the E. coli homolog exonuclease III. An additional regulatory function of APE1͞Ref1 was identified in Ca 2ϩ -dependent down-regulation of the parathyroid hormone and renin genes containing negativ...

The human AP-endonuclease (APE1/Ref-1), a multifunctional protein central to repairing abasic sites and single-strand breaks in DNA, also plays a role in transcriptional regulation. Besides activating some transcription factors, APE1 is directly involved in Ca 2+ -dependent downregulation of parathyroid hormone (PTH) expression by binding to negative calcium response elements (nCaREs) present in the PTH promoter. Here we show that APE1 is acetylated both in vivo and in vitro by the transcriptional co-activator p300 which is activated by Ca 2+ . Acetylation at Lys6 or Lys7 enhances binding of APE1 to nCaRE. APE1 stably interacts with class I histone deacetylases (HDACs) in vivo. An increase in extracellular calcium enhances the level of acetylated APE1 which acts as a repressor for the PTH promoter. Moreover, chromatin immunoprecipitation (ChIP) assay revealed that acetylation of APE1 enhanced binding of the APE1± HDACs complex to the PTH promoter. These results indicate that acetylation of APE1 plays an important role in this key repair protein's action in transcriptional regulation.

Colon cancer is the second leading cause of cancer death in the United States. Krüppel-like factor 4 (KLF4) is a transcription factor involved in both proliferation and differentiation in the colon. It is down-regulated in both mouse and human colonic adenomas and has been implicated as a tumor suppressor in the gut, whereas in breast cancer, KLF4 is an oncogene. KLF4 is also involved in reprogramming differentiated cells into pluripotent stem cells. KLF4 can act as a transcriptional activator or repressor, but the underlying mechanisms are poorly understood. We found that p300, a CREB-binding protein-related protein, interacts with KLF4 both in vitro and in vivo and activates transcription. We further made the novel observation that endogenous KLF4 is acetylated by p300/CBP in vivo and that mutations of the acetylated lysines resulted in a decreased ability of KLF4 to activate target genes, suggesting that acetylation is important for KLF4-mediated transactivation. Furthermore, we found that KLF4 differentially modulates histone H4 acetylation at the promoters of target genes. Co-transfection of KLF4 and HDAC3 resulted in a synergistic repression of a cyclin B 1 reporter construct. Our results suggest that KLF4 might function as an activator or repressor of transcription depending on whether it interacts with co-activators such as p300 and CREB-binding protein or co-repressors such as HDAC3.